Literature DB >> 18499656

2-aminoethoxydiphenyl borate alters selectivity of Orai3 channels by increasing their pore size.

Rainer Schindl1, Judith Bergsmann, Irene Frischauf, Isabella Derler, Marc Fahrner, Martin Muik, Reinhard Fritsch, Klaus Groschner, Christoph Romanin.   

Abstract

Stim1 in the endoplasmic reticulum and the three Orai (also termed CRACM) channels in the plasma-membrane are main components of native Ca(2+) release-activated Ca(2+) channels. A pharmacological hallmark of these channels is their distinct sensitivity to 2-aminoethoxydiphenyl borate (2-APB). Here we report that Orai3 currents can be robustly stimulated by 75 microm 2-APB independent of Stim1, whereas 2-APB at similar concentrations inhibited store-operated Orai1 currents. 2-APB did not only promote currents through Orai3 channels but also dramatically altered ion selectivity of Orai3 channels. This allowed for permeation of monovalent cations both in the inward as well as outward direction, which is in sharp contrast to the high Ca(2+) selectivity of store-operated Orai3 currents. An Orai3-R66W mutant, which lacked in analogy to the severe combined immune deficiency mutant Orai1-R91W store-operated activation, was also found to be resistant to 2-APB stimulation. The change in selectivity by 2-APB was associated with an increase in Orai3 minimum pore size from about 3.8A to more than 5.34 A. In line with a potential interaction of 2-APB with the Orai3 pore, among three pore mutants tested, the Orai3 E165Q mutant particularly resembled in its permeation properties those of 2-APB stimulated Orai3 and additionally exhibited a reduced response to 2-APB. In aggregate, stimulation of Orai3 currents by 2-APB occurred along with an alteration of the permeation pathway that represents a unique mechanism for regulating ion channel selectivity by chemical compounds.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18499656     DOI: 10.1074/jbc.M803101200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  80 in total

Review 1.  Orai3--the 'exceptional' Orai?

Authors:  Trevor J Shuttleworth
Journal:  J Physiol       Date:  2011-10-31       Impact factor: 5.182

Review 2.  Pharmacology of store-operated calcium channels.

Authors:  James W Putney
Journal:  Mol Interv       Date:  2010-08

Review 3.  Store-operated CRAC channels: function in health and disease.

Authors:  Anant B Parekh
Journal:  Nat Rev Drug Discov       Date:  2010-04-16       Impact factor: 84.694

Review 4.  Store-Operated Calcium Channels.

Authors:  Murali Prakriya; Richard S Lewis
Journal:  Physiol Rev       Date:  2015-10       Impact factor: 37.312

Review 5.  STIM and Orai: dynamic intermembrane coupling to control cellular calcium signals.

Authors:  Xiaoxiang Deng; Youjun Wang; Yandong Zhou; Jonathan Soboloff; Donald L Gill
Journal:  J Biol Chem       Date:  2009-05-27       Impact factor: 5.157

6.  Molecular determinants of the coupling between STIM1 and Orai channels: differential activation of Orai1-3 channels by a STIM1 coiled-coil mutant.

Authors:  Irene Frischauf; Martin Muik; Isabella Derler; Judith Bergsmann; Marc Fahrner; Rainer Schindl; Klaus Groschner; Christoph Romanin
Journal:  J Biol Chem       Date:  2009-06-08       Impact factor: 5.157

Review 7.  Permeation, selectivity and gating in store-operated CRAC channels.

Authors:  Beth A McNally; Murali Prakriya
Journal:  J Physiol       Date:  2012-05-14       Impact factor: 5.182

8.  K+ efflux agonists induce NLRP3 inflammasome activation independently of Ca2+ signaling.

Authors:  Michael A Katsnelson; L Graham Rucker; Hana M Russo; George R Dubyak
Journal:  J Immunol       Date:  2015-03-11       Impact factor: 5.422

9.  CRAC channel gating and its modulation by STIM1 and 2-aminoethoxydiphenyl borate.

Authors:  Sher Ali; Tao Xu; Xiaolan Xu
Journal:  J Physiol       Date:  2016-11-13       Impact factor: 5.182

Review 10.  The STIM-Orai Pathway: Orai, the Pore-Forming Subunit of the CRAC Channel.

Authors:  Aparna Gudlur; Patrick G Hogan
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.